Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ALVO
BCRX
Add up to 3 more stocks
ALVO
Alvotech
+0.41%
$6.13+0.02Delayed quote: Oct 6, 2026, 3:05 PM EDT
Market Cap
$2.07B
52W Range
$2.94 - $9.05
BCRX
BioCryst Pharmaceuticals, Inc.
-0.94%
$8.02-0.08Delayed quote: Oct 6, 2026, 3:05 PM EDT
Market Cap
$2.04B
52W Range
$6.00 - $11.31
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | N/A | N/A |
| P/S Ratio | 4.22 | 2.17 |
| P/FCF Ratio | N/A | 5.71 |
| EV/EBITDA | 41.95 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 60.5% | 97.8% |
| Operating Margin | 9.6% | 39.0% |
| Net Margin | -36.5% | -40.9% |
| ROE | N/A | N/A |
| ROA | -11.3% | -69.0% |
| ROIC | 3.6% | -89.7% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.65 | 2.32 |
| Quick Ratio | 0.96 | 2.29 |
| Debt/Equity | N/A | N/A |
| Interest Coverage | 0.52 | 4.32 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.